- Home
- LAZR vs AVIR Comparison
LAZR vs AVIR Comparison
Compare LAZR & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAZR
- AVIR
- Stock Information
- Founded
- LAZR 2012
- AVIR 2012
- Country
- LAZR United States
- AVIR United States
- Employees
- LAZR 800
- AVIR N/A
- Industry
- LAZR Auto Parts:O.E.M.
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- LAZR Consumer Discretionary
- AVIR Health Care
- Exchange
- LAZR Nasdaq
- AVIR Nasdaq
- Market Cap
- LAZR 272.0M
- AVIR 284.6M
- IPO Year
- LAZR N/A
- AVIR 2020
- Fundamental
- Price
- LAZR $8.17
- AVIR $3.12
- Analyst Decision
- LAZR Hold
- AVIR Hold
- Analyst Count
- LAZR 9
- AVIR 1
- Target Price
- LAZR $44.50
- AVIR $6.88
- AVG Volume (30 Days)
- LAZR 2.7M
- AVIR 216.8K
- Earning Date
- LAZR 11-11-2024
- AVIR 11-07-2024
- Dividend Yield
- LAZR N/A
- AVIR N/A
- EPS Growth
- LAZR N/A
- AVIR N/A
- EPS
- LAZR N/A
- AVIR N/A
- Revenue
- LAZR $75,025,000.00
- AVIR N/A
- Revenue This Year
- LAZR $2.70
- AVIR N/A
- Revenue Next Year
- LAZR $64.52
- AVIR N/A
- P/E Ratio
- LAZR N/A
- AVIR N/A
- Revenue Growth
- LAZR 27.61
- AVIR N/A
- 52 Week Low
- LAZR $7.85
- AVIR $2.88
- 52 Week High
- LAZR $55.35
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- LAZR 33.30
- AVIR 39.59
- Support Level
- LAZR $8.63
- AVIR $3.34
- Resistance Level
- LAZR $9.45
- AVIR $3.54
- Average True Range (ATR)
- LAZR 1.01
- AVIR 0.14
- MACD
- LAZR -0.45
- AVIR 0.01
- Stochastic Oscillator
- LAZR 3.64
- AVIR 4.49
About LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and advanced Technologies and Services. The majority of revenue is earned from the Autonomy Solutions segment which engaged in the design, manufacturing, and sale of LiDAR sensors catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries and advanced Technologies and Services provides semiconductors and related components, as well as design, test and consulting services to the Autonomy Solutions segment and various third-party customers, including government agencies and defense contractors, in markets generally unrelated to autonomous vehicles.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).